These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18618124)

  • 1. [Topical Mitomycin C as a therapy of conjunctival tumours].
    Schallenberg M; Niederdräing N; Steuhl KP; Meller D
    Ophthalmologe; 2008 Aug; 105(8):777-84. PubMed ID: 18618124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia.
    Khong JJ; Muecke J
    Br J Ophthalmol; 2006 Jul; 90(7):819-22. PubMed ID: 16672325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
    Finger PT; Czechonska G; Liarikos S
    Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
    Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
    Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment.
    Chalasani R; Giblin M; Conway RM
    Clin Exp Ophthalmol; 2006; 34(7):708-14. PubMed ID: 16970772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
    Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
    Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
    Kurli M; Finger PT
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
    Sacu S; Ségur-Eltz N; Horvat R; Lukas JR; Zehetmayer M
    Am J Ophthalmol; 2003 Aug; 136(2):375-7. PubMed ID: 12888073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
    Werschnik C; Lommatzsch PK
    Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance.
    Chaparro Tapias TA; Díaz Díaz AL; Secondi R; Coy Villamil H; Sánchez España JC
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Nov; 93(11):558-561. PubMed ID: 30072188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%].
    Ramos-López JF; Martínez-Costa Pérez R; Cisneros Lanuza AL; Francés Muñoz E; Monte Boque E; Muñoz Gómez MC; López-Sánchez EV; Menezo Rozalén JL
    Arch Soc Esp Oftalmol; 2004 Aug; 79(8):375-8. PubMed ID: 15306963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical mitomycin C for the treatment of conjunctival tumor.
    Ozcan AA; Sizmaz S; Yagmur M
    Ophthalmologica; 2007; 221(1):14-7. PubMed ID: 17183195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
    Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
    Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
    Ditta LC; Shildkrot Y; Wilson MW
    Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
    Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
    Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
    Shields CL; Naseripour M; Shields JA
    Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined excision, cryotherapy, and intraoperative mitomycin C (EXCRIM) for localized intraepithelial and squamous cell carcinoma of the conjunctiva.
    Sarici AM; Arvas S; Pazarli H
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2201-4. PubMed ID: 23949688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical mitomycin C and radiation induce conjunctival DNA-polyploidy.
    Cartsburg O; Kallen C; Hillenkamp J; Sundmacher R; Pomjanski N; Böcking A
    Anal Cell Pathol; 2001; 23(2):65-74. PubMed ID: 11904462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.